Breast cancer is a leading cause of cancer-related deaths in Botswana, and there is a dire need to improve timely access to care. Through research and training, the Botswana-Rutgers Partnership for Health is working to identify and address crucial deficiencies in information and support.
While the overall rates of HIV/AIDS have decreased, the risk of infections within certain populations has surged. New Jersey Medical School faculty member Shobha Swaminathan is a clinical site leader for a vaccine trial that aims to provide HIV immunity for life.
Excessive weight gain during pregnancy, along with associated health risks for pregnant women and their children, is on the rise in Nepal. Through a Rutgers Global Health Institute seed grant, Shristi Rawal is investigating the extent, possible causes, and outcomes of this problem.
A study involving the all-women Nikumbuke Soccer League in Kenya is exploring the effects of women’s sports on social norms related to gender-based violence. Bloustein School associate professor Francis Barchi is collecting data via surveys, focus group discussions, and in-depth interviews in the seven villages that have women’s teams.
Tuberculosis is a global threat, with the heaviest burden falling on people living in urban slums. Stephan Schwander is investigating the role urban outdoor air pollution might play.
A new Rutgers study aims to generate knowledge about factors that affect population health and opportunities to advance equity-promoting policies in the state.
Rutgers Global Health Institute’s Botswana team was selected to receive up to $25,000 in grant funding for its “Improving Timely Access to Care for Women with Advanced Stage Breast Cancer in Botswana” research study.
Every year, millions of people in developing countries die from tropical infectious diseases. Rutgers scientists are leading an effort to help researchers in these countries discover botanical compounds with medicinal potential.
Rutgers researchers are developing a broad-spectrum vaccine that could save hundreds of thousands of lives.
Investigators at Rutgers Cancer Institute of New Jersey found that black pediatric patients with Hodgkin lymphoma have significantly worse overall survival rates after five years than white patients.
